| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 8, 2004
From the National Institute on Drug Abuse (H.S., G.-J.C., B.K.H., P.C.B., Y.W.), National Institutes of Health, Baltimore, Md; and the Center for Aging and Brain Repair (B.K.H., P.C.B.), University of South Florida, Tampa, Fla. * To whom correspondence should be addressed. E-mail: ywang{at}intra.nida.nih.gov.
Background and Purpose--Purinergic nucleoside inosine elicits protection and regeneration during various injuries. The purpose of this study was to examine the protective effects of inosine against cerebral ischemia. Methods--Adult Sprague-Dawley rats were anesthetized. Inosine, hypoxathine, or vehicle was administered intracerebroventricularly before transient right middle cerebral artery occlusion (MCAo). Animals were placed in behavioral chambers 2 days to 2 weeks after MCAo and then euthanized for tri-phenyl-tetrazolium chloride staining. Glutamate release was measured by microdialysis/high-performance liquid chromatography, and single-unit action potentials were recorded from neurons in the parietal cortex. Results--Stroke animals receiving inosine pretreatment demonstrated a higher level of locomotor activity and less cerebral infarction. Intracerebroventricular administration of the same dose of hypoxanthine did not confer protection. Coadministration of selective A3 receptor antagonist 3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1, 4-(±)-dihydropyridine-3,5-dicarboxylate (MRS1191) significantly reduced inosine-mediated protection. Inosine did not alter basal glutamate release, nor did it reduce ischemia-evoked glutamate overflow from cerebral cortex. However, inosine antagonized glutamate-induced electrophysiological excitation in cerebral cortical neurons. Conclusions--Inosine inhibits glutamate postsynaptic responses and reduces cerebral infarction. Its protective effect against ischemia/reperfusion-related insults may involve activation of adenosine A3 receptors.
Accepted on November 25, 2004
Inosine Reduces Ischemic Brain Injury in Rats
Hui Shen MD;
This article has been cited by other articles:
![]() |
L. Zai, C. Ferrari, S. Subbaiah, L. A. Havton, G. Coppola, S. Strittmatter, N. Irwin, D. Geschwind, and L. I. Benowitz Inosine Alters Gene Expression and Axonal Projections in Neurons Contralateral to a Cortical Infarct and Improves Skilled Use of the Impaired Limb J. Neurosci., June 24, 2009; 29(25): 8187 - 8197. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shen, C.-C. Kuo, J. Chou, A. Delvolve, S. N. Jackson, J. Post, A. S. Woods, B. J. Hoffer, Y. Wang, and B. K. Harvey Astaxanthin reduces ischemic brain injury in adult rats FASEB J, June 1, 2009; 23(6): 1958 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Schwarzschild, S. R. Schwid, K. Marek, A. Watts, A. E. Lang, D. Oakes, I. Shoulson, A. Ascherio, and and the Parkinson Study Group PRECEPT Investigator Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease Arch Neurol, June 1, 2008; 65(6): 716 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Naydenova, J. B. Rose, and I. R. Coe Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2687 - H2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuda, H. Shen, G.-J. Chen, B. Harvey, and Y. Wang Inosine, Calcium Channels, and Neuroprotection Against Ischemic Brain Injury * Response: Stroke, September 1, 2005; 36(9): 1823 - 1823. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |